Terms: = Uterine cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Prognosis
19 results:
1. Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
Roser E; Harter P; Zocholl D; Denschlag D; Chekerov R; Wimberger P; Kurzeder C; Hasenburg A; Muallem MZ; Mustea A; Emons G; Zeimet AG; Beck F; Arndt T; Brucker SY; Kommoss S; Heitz F; Welz J; Egger EK; Kalder M; Buderath P; Klar M; Marth C; Ulrich UA; Weigel M; Traub L; Anthuber C; Strauss H; Hanker L; Link T; Kubiak K; Melekian B; Hornung D; Pölcher M; Lampe B; Krauß T; Keilholz U; Flörcken A; Pietzner K; Sehouli J
Int J Gynecol Cancer; 2023 Feb; 33(2):223-230. PubMed ID: 36631151
[TBL] [Abstract] [Full Text] [Related]
2. Prevalence and Prognostic Relevance of Homologous Recombination Repair Gene Mutations in uterine Serous Carcinoma.
Dong L; Wang T; Li N; Yao H; Ying J; Wu L; Yuan G
Cells; 2022 Nov; 11(22):. PubMed ID: 36428992
[TBL] [Abstract] [Full Text] [Related]
3. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human uterine Leiomyosarcoma.
Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
[TBL] [Abstract] [Full Text] [Related]
4. Genomic landscape of endometrial carcinomas of no specific molecular profile.
Momeni-Boroujeni A; Nguyen B; Vanderbilt CM; Ladanyi M; Abu-Rustum NR; Aghajanian C; Ellenson LH; Weigelt B; Soslow RA
Mod Pathol; 2022 Sep; 35(9):1269-1278. PubMed ID: 35365770
[TBL] [Abstract] [Full Text] [Related]
5. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer - a population-based study.
Scharl S; Gerken M; Sprötge T; Kronberger K; Scharl A; Ignatov A; Ortmann O; Kölbl O; Klinkhammer-Schalke M; Papathemelis T
Acta Oncol; 2021 Jul; 60(7):897-903. PubMed ID: 33905297
[TBL] [Abstract] [Full Text] [Related]
7. atm mutations as an independent prognostic factor and potential biomarker for immune checkpoint therapy in endometrial cancer.
Sun L; Wang RC; Zhang Q; Guo LL
Pathol Res Pract; 2020 Aug; 216(8):153032. PubMed ID: 32703496
[TBL] [Abstract] [Full Text] [Related]
8. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
9. MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells.
Singh N; Bhakuni R; Chhabria D; Kirubakaran S
BMC Res Notes; 2020 Mar; 13(1):146. PubMed ID: 32160908
[TBL] [Abstract] [Full Text] [Related]
10. Genomic Characterization of HPV-related and Gastric-type Endocervical Adenocarcinoma: Correlation With Subtype and Clinical Behavior.
Hodgson A; Howitt BE; Park KJ; Lindeman N; Nucci MR; Parra-Herran C
Int J Gynecol Pathol; 2020 Nov; 39(6):578-586. PubMed ID: 31855952
[TBL] [Abstract] [Full Text] [Related]
11. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
Wang Y; Liu D; Jin X; Song H; Lou G
Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
[TBL] [Abstract] [Full Text] [Related]
12. microRNA-136 inhibits proliferation and promotes apoptosis and radiosensitivity of cervical carcinoma through the NF-κB pathway by targeting E2F1.
Lu HJ; Jin PY; Tang Y; Fan SH; Zhang ZF; Wang F; Wu DM; Lu J; Zheng YL
Life Sci; 2018 Apr; 199():167-178. PubMed ID: 29452167
[TBL] [Abstract] [Full Text] [Related]
13. The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis.
Chen S; Tao M; Zhao L; Zhang X
Medicine (Baltimore); 2017 Oct; 96(40):e7981. PubMed ID: 28984757
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.
Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
Gynecol Endocrinol; 2018 Feb; 34(2):171-174. PubMed ID: 28937296
[TBL] [Abstract] [Full Text] [Related]
15. ADC Histogram Analysis of Cervical cancer Aids Detecting Lymphatic Metastases-a Preliminary Study.
Schob S; Meyer HJ; Pazaitis N; Schramm D; Bremicker K; Exner M; Höhn AK; Garnov N; Surov A
Mol Imaging Biol; 2017 Dec; 19(6):953-962. PubMed ID: 28315203
[TBL] [Abstract] [Full Text] [Related]
16. Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
Ho CK; Kornaga EN; Klimowicz AC; Enwere EK; Dean M; Bebb GD; Phan T; Ghatage P; Magliocco AM; Lees-Miller SP; Doll CM
Gynecol Oncol; 2017 Apr; 145(1):176-184. PubMed ID: 28131528
[TBL] [Abstract] [Full Text] [Related]
17. Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.
Gumulec J; Raudenska M; Adam V; Kizek R; Masarik M
PLoS One; 2014; 9(1):e85346. PubMed ID: 24416395
[TBL] [Abstract] [Full Text] [Related]
18. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
[TBL] [Abstract] [Full Text] [Related]
19. [Gestational trophoblastic disease. Clinical course and results of treatment].
Sablińska B; Borowiak J; Drabik M
Nowotwory; 1989; 39(3-4):176-84. PubMed ID: 2561536
[TBL] [Abstract] [Full Text] [Related]